Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Group Receiving Hypopressive Abdominal Gymnastic

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT03108339CompletedPrimary

Markers of Outcome - a Cohort Study of LBP in Primary Health Care

NCT02273908CompletedPrimary

PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin

NCT02721914Not ApplicableCompletedPrimary

The Effectiveness of the Massage and the Hypopressive Abdominal Gymnastics on Low Back Pain (MAS-GAH)

Showing all 3 trials

Research Network

Common Treatments

  • Group Receiving Hypopressive Abdominal Gymnastic1
  • Guideline Recommended Physiotherapy Care1
  • No Intervention1
  • Group Receiving Massotherapy1
  • Group Receiving Massotherapy Hypopressive Abdominal Gymnastic1

Active Sponsors

  • University of Seville1
  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
  • Karolinska Institutet1

Top Investigators

Activity Timeline